JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Defining three ferroptosis-based molecular subtypes and developing a prognostic risk model for high-grade serous ovarian cancer

  • 0Department of Obstetrics and Gynecology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China.
Aging +

|

May 25, 2024

|

May 25, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Ferroptosis, a cell death form, shows distinct subtypes in ovarian cancer (OV), impacting prognosis and treatment sensitivity. A new ferroptosis-related risk model aids in predicting outcomes and guiding targeted therapies.

Area Of Science

  • Oncology
  • Cell Death Mechanisms
  • Cancer Biomarkers

Background

  • Ferroptosis, a newly defined regulated cell death, is recognized as a potential biomarker in ovarian cancer (OV).
  • The intricate mechanisms of ferroptosis within the tumor microenvironment (TME) and its clinical predictive significance in OV require further elucidation.

Purpose Of The Study

  • To classify molecular subtypes of high-grade serous ovarian cancer based on ferroptosis-related genes.
  • To develop and validate a ferroptosis-based prognostic model for ovarian cancer.
  • To investigate the association between ferroptosis subtypes and the tumor microenvironment, immune landscape, and clinical characteristics.

Main Methods

  • Transcriptome data from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases were utilized.
  • Consensus clustering analysis based on ferroptosis-correlated genes from FerrDb was performed to define molecular subtypes.
  • A prognostic model was constructed using 8 ferroptosis-related genes and validated across cohorts.

Main Results

  • Three distinct molecular subtypes of OV were identified, with subtype C3 showing the most favorable prognosis and C1 associated with mesenchymal features and poor outcomes.
  • A robust 8-gene ferroptosis-related risk model demonstrated strong predictive performance for patient prognosis.
  • High-risk patients exhibited enriched epithelial-to-mesenchymal transition (EMT) pathways, altered immune cell infiltration, and immune escape, correlating with worse outcomes.

Conclusions

  • The study successfully defined ferroptosis-related molecular subtypes in ovarian cancer, offering insights into prognosis and TME interactions.
  • A validated ferroptosis-based risk model can predict clinical outcomes and potential therapeutic sensitivities in ovarian cancer patients.
  • These findings provide a foundation for understanding ferroptosis in OV and developing targeted therapeutic strategies.

Keywords: